LINDSAY DOMANGUE: Open Payments
NPI 1639486749 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 104 payments from 26 companies in 2025. Trend: 2023 $2,441 · 2024 $1,942 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $360 |
| Novo Nordisk Inc | 10 | $161 |
| PFIZER INC. | 8 | $153 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $137 |
| Inspire Medical Systems, Inc. | 3 | $81 |
| ABIOMED | 3 | $52 |
| Abbott Laboratories | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Dexcom, Inc. | 2 | $42 |
Products named: TRELEGY ELLIPTA, Kerendia, QULIPTA, NURTEC ODT, VRAYLAR, Wegovy, INSPIRE, Ozempic.
Industry payments across TX — which companies pay providers there.
